Partial victory for GSK against BioNTech and Pfizer in UPC dispute
The local division The Hague ruled that BioNTech and Pfizer infringe GSK’s EP 2 590 626. The patent protects liposomes used to deliver RNA in vaccines (case ID: UPC-CFI-0001511/2025). The panel under presiding judge Edger Brinkman upheld the patent almost in full. Only one claim was revoked.